image
Collegium Pharmaceutical, Inc. COLL
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
Watchlist
$ 29.58
-2.28 %
$ 954 M
Market Cap
12.64
P/E
INCOME STATEMENT
567 M REVENUE
22.17%
Growth Rates
1Year 22.17%
3Years 22.28%
5Years 15.11%
7Years 129.10%
10Years 0.00%
167 M OPERATING INCOME
259.66%
Growth Rates
1Year 259.66%
3Years 226.57%
5Years 58.72%
7Years 20.90%
10Years 28.64%
48.2 M NET INCOME
292.60%
Growth Rates
1Year 292.60%
3Years 21.65%
5Years 26.43%
7Years 14.06%
10Years 17.40%
EFFICIENCY
Earnings Waterfall Collegium Pharmaceutical, Inc.
image
Revenue 567 M
Cost Of Revenue 241 M
Gross Profit 326 M
Operating Expenses 159 M
Operating Income 167 M
Other Expenses 119 M
Net Income 48.2 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
REVENUE
Revenue 566.8 463.9 276.9 310.0 296.7 280.4 28.5 1.7 0 0 0
GROSS PROFIT
Cost Of Revenue 240.6 254.4 126.3 130.2 193.7 165.7 2.6 0.2 0.2 0 0
Gross Profit 326.2 209.5 150.6 179.8 103.0 114.7 25.9 1.5 (0.2) 0 0
OPERATING INCOME
Operating Expenses 159.2 176.2 128.4 123.6 126.8 135.4 101.3 95.6 26.9 17.7 16.0
Selling, General and Administrative Expenses 159.2 172.2 119.0 113.8 116.4 126.8 92.8 80.6 18.9 2.7 1.9
Research and Development Expenses 0 4.0 9.5 9.8 10.3 8.7 8.6 14.9 8.0 15.0 14.2
Operating Income 167.0 (104.6) (46.7) (5.1) (23.7) (20.7) (75.4) (94.1) (26.9) (17.7) (16.0)
PRE-TAX INCOME
Interest Income Expense 83.3 63.2 21.0 28.9 0.9 20.1 0.6 94 K 0.4 0.3 76 K
Total Other Income (91.2) (62.2) (21.0) (28.6) 1.0 (18.4) 0.6 94 K (0.3) (0.3) (0.2)
Pre-Tax Income 75.7 (28.8) (3.4) 27.6 (22.7) (39.1) (74.9) (94.2) (27.3) (17.9) (16.2)
NET INCOME
Tax Provision 27.6 (3.8) (74.9) 0.8 (14.6) (110.9) (1.2) 94 K 91 K 0.3 79 K
Net Income 48.2 (25.0) 71.5 26.8 (8.1) (39.1) (74.9) (94.2) (27.3) (17.9) (16.2)
EPS 1.6 0.74 2.05 0.78 0.24 1.19 2.47 3.88 2.01 2.4 2.17